Site icon OncologyTube

Germline Mutations and the Impact on NSCLC Patients

Ravi Salgia, MD, Professor and Chair, Department of Medical Oncology and Therapeutics Research, Associate Director for Clinical Sciences, Arthur and Rosalie Kaplan Endowed Chair in Medical Oncology, City of Hope addresses on germline mutations and the impact they have on non-small cell lung cancer (NSCLC) patients.

Exit mobile version